An expert review report released by the Food and Drug Administration (FDA) Monday raised doubts as to whether the vaccine developed by Taiwan-based United Biomedical Inc. (UBI) Asia offers sufficient protection against COVID-19 variants.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close down 0.19%
10/31/2025 02:23 PM - Culture
Sweet discovery! Tainan project unearths historical sugar industry ruins
10/31/2025 02:09 PM - Politics
Special bill on Hualien post-flood reconstruction clears Legislature
10/31/2025 02:04 PM - Society
Meta warns of scams ahead of Taiwan's NT10,000 cash handout
10/31/2025 12:44 PM - Business
U.S. dollar up in Taipei trading
10/31/2025 10:10 AM